Aix-en-Provence, Provence-Alpes-Côte d'Azur, France The fund has no exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Bloomup, Carru00e9 d'Artistes, Altrad Group We can highlight the next thriving fund investment areas, such as Craft Beer, Art.
The top activity for fund was in 2017. Comparing to the other companies, this Sofipaca performs on 19 percentage points less the average number of lead investments. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year.
The standard case for the fund is to invest in rounds with 3-4 partakers. The meaningful sponsors for the fund in investment in the same round are IDIA Capital Investissement, Paca Investissement, Bpifrance. In the next rounds fund is usually obtained by Societe Generale, CM-CIC Innovation, BNP Paribas Private Equity.
Related Funds
| Fund Name | Location |
| 32 Equity | New York, New York, United States |
| A.L. Mailman Foundation | - |
| AbbVie | Chicago, Illinois, United States |
| Advent Life Sciences | England, London, United Kingdom |
| CloudWise | Beijing, Beijing, China |
| Fernbrook Capital Management LLC | New York, New York, United States |
| Greentree Investment Comany | - |
| International Private Bank (IPB) | - |
| Medidata Solutions | New York, New York, United States |
| Miele Venture | - |
| Newlight Partners | New York, New York, United States |
| NOWLIT Solutions Corp | Alberta, Canada, Fort Mcmurray |
| Old Willow Partners | Minnesota, Northfield, United States |
| Prisma Capital | Brazil, Itaim, Minas Gerais |
| SRB Management | Dallas, Texas, United States |
| Stream Hill Angels | Beijing, Beijing, China |
| TudorVentures | - |
| Urca Angels | Brazil, São Paulo, Sao Paulo |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
HalioDx | $21M | 17 Jan 2018 | Marseille, Provence-Alpes-Côte d'Azur, France | ||
Bloomup | 24 Sep 2014 | France, Provence-Alpes-Côte d'Azur, France | |||
Provepharm life Solutions | $3M | 01 Dec 2011 | Marseille, Provence-Alpes-Côte d'Azur, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
HalioDx | $21M | 17 Jan 2018 | Marseille, Provence-Alpes-Côte d'Azur, France | ||
Bloomup | 24 Sep 2014 | France, Provence-Alpes-Côte d'Azur, France | |||
Provepharm life Solutions | $3M | 01 Dec 2011 | Marseille, Provence-Alpes-Côte d'Azur, France |
